MagnetOs Flex Matrix is a new open matrix bone graft with a unique fibrillar - and flexible - structure that optimizes the effect of our established NeedleGrip surface technology. By exposing more of the NeedleGrip surface to the surrounding biological environment, MagnetOs Flex Matrix grows bone even in soft tissue for a more predictable fusion.*†‡1-3
This product absorbs up to ten times as much BMA as competitors’ bone grafts and it’s extremely convenient to use, with excellent granule retention.4
Schedule a meeting with one of our experts
View the instructional video
Download the Surgical Preparation Guide.
References: 1. Van Dijk, et al. eCM. 2021;41:756-73. 2. Duan, et al. eCM. 2019;37:60-73. 3. Van Dijk, et al. Clin Spine Surg. 2020;33(6):E276-E287. 4. Data on File.
*Results from in vivo laboratory testing may not be predictive of clinical experience in humans. For important safety and intended use information please visit kurosbio.com. †MagnetOs is not cleared by the FDA as an osteoinductive bone graft. ‡MagnetOs has been proven to generate more predictable fusions than two commercially available alternatives in an ovine model of posterolateral fusion.
MagnetOs and NeedleGrip are trademarks of Kuros Biosciences.
PROMO/MAG/US/032-22/R00
Connect with us
To keep up with the latest news and research in
our world, connect with Kuros on LinkedIn.
Kuros Biosciences USA, Inc.
22 Boston Wharf Rd., 7th Floor
Boston, MA 02210
USA